Weekly low dose epirubicin in elderly cancer patients

Tumori

Volumn 82, Issue 4, 1996, Pages 369-371

  Nicolella, Dario ^a   Grimaldi, Giuseppe ^a   Colantuoni, Giuseppe ^a   Belli, Mario ^a   Frasci, Giuseppe ^b   Perchard, John ^b   Comella, Pasquale ^b  

^a S G MOSCATI HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

elderly tumors; epirubicin; weekly monochemotherapy

Indexed keywords

EPIRUBICIN;

AGED; ANEMIA; ARTICLE; CARCINOMA; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION;

EID: 0029824485     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200414     Document Type: Article

References (19)

1. Balducci L., Mowrey K., Parker M.: Pharmacology of antineoplastic agents in older patients. In: Geriatric oncology, Balducci L., Lyman G.H., Ershler W.B. (Eds.), pp.169-180, Lippincott J.B., Philadelphia, USA, 1992.
2. Beretta G., Tabiadon T., Clerici M., Tedeschi L., Ratti D., Luporini G.: Clinical evaluation of 4′-epiadryamicin in a new therapeutic regimen. Proc. 2nd Conf. on a Clinical Oncology (ECCO) 33: 67, 1983.
3. Cersosimo R.J., Hong W.K.: Epirubicin: a review of pharmacological, clinical activity and adverse side effect of an adryamicin analogue. J. Clin. Oncol., 4: 425-439, 1986.
4. Chlebowsky R.T., Paroly W.S., Pugh R.P., Hueser J., Jacobs E.M., Pajak T.F., Bateman J.R.: Adryamicin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity. Cancer Treat. Rep., 64: 47, 1980.
5. Colleoni M., Gaion F., Nelli P., Colmellere G.M., Manente P.: Weekly vinorelbine in elderly patients with non small cell lung cancer. Tumori, 80: 448-452, 1994.
6. Evans B.D., Macauley, Smith I.E.: Weekly low dose epirubicin. A phase II study in breast cancer amd small cell lung cancer. Clin. Trials J., 24 (Suppl. 1): 107-110, 1987.
7. Frasci G., Iaffaioli V., Conforti F.: Epirubicin in a weekly schedule for the treatment of refractory ovarian cancer. 8th International Meeting of Gynaecological Oncology, Barcellona, Spain, 1993.
8. Gatzmeier U., Hecymayr M.: Chemotherapy of SCLC in elderly patients with 4′-epirubicin weekly as a single agent. J. Cancer Res. Clin. Oncol., 114 (Suppl): 189-193, 1988.
9. Jones W.G., Mattson W.: Phase II study of weekly low dose 4′-epidoxorubicin in advanced postmenopausal breast cancer. Cancer Treat. Rep., 68: 675-677, 1984.
10. Kennedy B.J.: Aging and cancer. In: Geriatric oncology. Balducci L., Lyman G.H., Ershler W.B. (Eds.), pp. 1-8, Lippincott J.B., Philadelphia, USA, 1992.
11. Kolaric K., Potrebica V., Cervek J.: Phase II clinical trial of 4′-epidoxorubicin in metastatic solid tumours. J. Cancer Res. Clin. Oncol., 106: 148-152, 1983.
12. Mattson W., Borgstrom S., Landberg T.: A weekly schedule of low dose-doxorubicin in treatment of advanced breast cancer. Clin. Ther., 5: 193-203, 1982.
13. Pummer K., Stettner H., Lehnert M.: Phase II study of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer. Proc. Am. Soc. Clin. Oncol., 12: 229-233, 1993.
14. Sigurdsson H., Johansson-Terse I., Aspegren K., Landberg T., Anderson T., Borgstrom S., Thelin A.M.: Weekly low dose doxorubicin in advanced breast cancer. Radiother. Oncol., 7: 133-139, 1986.
15. Snyder S., Bishop J., Brodie G., Burns W., Coates A., Levi J., Raghavan D., Scwharz M., Tattersall M., Thompson D., Woods R., Zlogas V.: Phase I study of epirubicin given on a weekly schedule. Cancer Treat. Rep., 71: 273-276, 1987.
16. Torti F.M., Aston D., Lum B.L.: Weekly doxorubicin in endocrin-refractory carcinoma of the prostate. J. Clin. Onc., 1: 477-482, 1983.
17. Tucci E., Algeri R., Guarnieri A., Pepi F., Sapio L., Bastreghi G., Pirtoli L.: Weekly epirubicin in advanced breast cancer. Tumori, 74: 689-692, 1988.
18. Twelves C.J., O'Reilly S., Coleman R.E., Richards M.A., Rubens R.D.: Weekly epirubicin for liver metastases in breast cancer. Proc. Am. Soc. Clin. Oncol., 8: 32, 1989.
19. Valdivieso M., Burgess M.A., Ewer R.S., Mackay B., Wallace S., Benjamin S., Ali M.D., Bodey G.P., Freiretch E.J.: Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective randomized study. J. Clin. Oncol., 2: 207-214, 1984.